| ²é¿´: 1495 | »Ø¸´: 4 | |||
sophielajľ³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ŵ»ªÎªÊ²Ã´ÔÚÃÀ¹úÍ£Ö¹ÏúÊÛ¸ñÁÐÎÀ½ºÄÒ¼Á£¿
|
ÈçÌâ¡¡![]() ![]() ![]() ÕÒÁË´ó°ëÌ죬ÕÒµ½Ò»Ìõ¿´ËÆÓÐÓÃȴûÓõÄÐÅÏ¢£º Hyman, Phelps & McNamara, PC, submitted a citizen petition dated June 3, 2010 (Docket No. FDA¨C2010¨CP¨C0275), under 21 CFR 10.30, requesting that the Agency determine whether GLEEVEC (imatinib mesylate) Capsules, 50 mg and 100 mg, were withdrawn from sale for reasons of safety or effectiveness. After considering the citizen petition and reviewing Agency records, FDA has determined under ¡ì 314.161 that GLEEVEC (imatinib mesylate) Capsules, 50 mg and 100 mg were not withdrawn for reasons of safety or effectiveness. £¨ÃÀ¹úÁª°î¹«±¨£¨2010-12-7£©£© |
» ²ÂÄãϲ»¶
070700Çóµ÷¼Á
ÒѾÓÐ1È˻ظ´
ÖÆÒ©¹¤³ÌרҵÕÐÊÕµ÷¼Á£¬ÒªÇó¹ý¹ú¼ÒÏß
ÒѾÓÐ0È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ68È˻ظ´
ÎåÒØ´óѧҩÎﻯѧÉúÎïѧÍŶÓ-ÀîÀ¼Çå¿ÎÌâ×éÕÐÊÕµ÷¼ÁѧÉú
ÒѾÓÐ0È˻ظ´
Çóµ÷¼Á×Ü·Ö327
ÒѾÓÐ1È˻ظ´
Çóµ°°×ÍÆ¼ö£¬ÓÃÓÚʵÑé½ÌѧÖе°°×Ò©ÎïµÄ±í´ï
ÒѾÓÐ0È˻ظ´
Çóµ°°×ÍÆ¼ö£¬ÓÃÓÚʵÑé½ÌѧÖе°°×Ò©ÎïµÄ±í´ï
ÒѾÓÐ0È˻ظ´
Çóµ°°×ÍÆ¼ö£¬ÓÃÓÚʵÑé½ÌѧÖе°°×Ò©ÎïµÄ±í´ï
ÒѾÓÐ2È˻ظ´
342Ò»Ö¾Ô¸´ó¹¤ÖÆÒ©×¨Ë¶£¬±¾¿Æ211£¬Çóµ÷¼Á
ÒѾÓÐ2È˻ظ´
wnting
ÖÁ×ðľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 12556.2
- Ìû×Ó: 340
- ÔÚÏß: 119.1Сʱ
- ³æºÅ: 423361
- ×¢²á: 2007-07-21
- ÐÔ±ð: GG
- רҵ: ÁÙ´²Ò©Àí
2Â¥2013-09-10 13:59:17
sophielaj
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 3995.6
- ºì»¨: 1
- Ìû×Ó: 53
- ÔÚÏß: 93Сʱ
- ³æºÅ: 602326
- ×¢²á: 2008-09-14
- ÐÔ±ð: MM
- רҵ: ÉúÎï¼¼ÊõÒ©Îï
3Â¥2013-09-11 09:00:57
wnting
ÖÁ×ðľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 12556.2
- Ìû×Ó: 340
- ÔÚÏß: 119.1Сʱ
- ³æºÅ: 423361
- ×¢²á: 2007-07-21
- ÐÔ±ð: GG
- רҵ: ÁÙ´²Ò©Àí
4Â¥2013-09-11 16:30:45
sophielaj
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 3995.6
- ºì»¨: 1
- Ìû×Ó: 53
- ÔÚÏß: 93Сʱ
- ³æºÅ: 602326
- ×¢²á: 2008-09-14
- ÐÔ±ð: MM
- רҵ: ÉúÎï¼¼ÊõÒ©Îï
5Â¥2013-09-12 16:27:13














»Ø¸´´ËÂ¥